MAY 12, 2021, 2-5pm (CEST)

CELLINK DIGITAL CAPITAL MARKETS DAY

Agenda

14.00-14.05 Welcome

Isabelle Ljunggren, Head of Communications CELLINK

14.05-14.15 Introduction to the future of medicine

Dr. Robert Langer, MIT, co-founder of Moderna and Scientific Advisor to CELLINK’s Scientific Advisory Board

14.15-14.40 Bioconvergence agenda and strategic focus areas 2021 

Erik Gatenholm, CEO CELLINK

14.40-15.00 Financial update Q1, 2021 and M&A agenda

Gusten Danielsson, CFO CELLINK

15.00-15.20 Introduction to Biosciences

Dr. Jonas Schöndube, Business Area Manager Biosciences

15.20-15.25 Break (5 min)

15.25-15.45 Introduction to Bioprinting

Artur Aira, Business Area Manager Bioprinting & Cecilia Edebo, Managing Director CELLINK Bioprinting

15.45-15.55 The BIO MDX Series

Dr. Héctor Martínez, CTO & Cecilia Edebo, Managing Director CELLINK Bioprinting

15.55-16.15 How we work and interact with our engaged customers and partners

Dr. Itedale Namro Redwan, CSO Bioprinting & Mariana Andrade, Head of Customer Success CELLINK

16.15-16.20 Break (5 min)

16.20-16.40 Introduction to Industrial Solutions

Dr. Holger Eickhoff, Business Area Manager Industrial Solutions

16.40-16.55 Q&A session 

Moderator Ulrik Trattner, Equity Research, Carnegie

16.55-17.00 Thank you

Isabelle Ljunggren, Head of Communications CELLINK

Videos

Introduction to the future of medicine

Bioconvergence agenda and strategic focus areas 2021

Financial update Q1, 2021 and M&A agenda

Introduction to Biosciences

Introduction to Bioprinting

The BIO MDX Series

How we work and interact with our engaged customers and partners

Introduction to Industrial Solutions

Q&A session